<DOC>
	<DOCNO>NCT01170351</DOCNO>
	<brief_summary>Untreated Autoimmune hepatitis ( AIH ) progressive disease . Mainstay treatment corticosteroid ( CS ) . In addition ineffective substantial minority case , corticosteroid side-effects hamper effective therapy another subgroup . Alternative option induction remission limit . There report successful salvage therapy Cyclosporine-A ( CsA ) steroid refractory case . In addition , open-labeled study show efficacy Cyclosporine-A treatment-naive AIH patient . There study compare CsA CS head head trial . The investigator aim assess efficacy tolerability CsA directly CS induction remission treatment-naive AIH patient .</brief_summary>
	<brief_title>Cyclosporine-A Versus Prednisolone Induction Remission Auto-immune Hepatitis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Autoimmune</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1665 year old individual probable definite AIH accord revise AIH criterion . Willing able participate study Nonconsenting patient decompensated cirrhosis , i.e . clinical ascites , hepatic encephalopathy , history variceal bleed Presence serious concomitant cardiovascular , pulmonary renal condition Presence active malignant disorder</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>autoimmune hepatitis</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>cysclosporine-A</keyword>
	<keyword>treatment</keyword>
	<keyword>treatment-naive</keyword>
	<keyword>induction remossion</keyword>
	<keyword>efficacy</keyword>
	<keyword>tolerability</keyword>
</DOC>